SIPPET INVESTIGATORS

(in order of number of randomized patients)

  • A. El-Beshlawy, S.A. Habib and N. Omar from Pediatric Hematology Department, Cairo University Pediatric Hospital, Cairo, Egypt  (38 patients);
  • M. Elalfy, N. Elbarbary, G. Nevine and S. Abdelghani from Faculty of Medicine, Ain Shams Center, University – Department Pediatrics, Cairo, Egypt (38 patients);
  • V. Ramanan and S. Lohade from Jehangir Clinical Development Centre, Department of Hematology, Jehangir Hospital Premises, Pune, India (22 patients);
  • P. Eshghi, M. Ahmadinejad and B.H. Panah from Congenital Pediatric Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (19 patients);
  • S. Hanagavadi, M.S. Hanagavadi and M. Kumar from J J M Medical College, Davangere, India (15 patients);
  • R. Varadarajan from Centre for Blood Disorders, Chennai, India (15 patients);
  • M. Karimi, A. Afrasiabi and Z. Zahedi from Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran (13 patients);
  • M.V. Manglani and S.M. Sharma from Lokmanya Tilak Municipal Medical College & General Hospital, Sion, Mumbai, India  (9 patients);
  • C. Ross and S. Subramanian from St. John’s Medical College Hospital, Bangalore, India (8 patients);
  • G. Young from Children’s Hospital Los Angeles (CHLA), Los Angeles, USA (8 patients);
  • T. Seth and R. Saxena from All India Institute of Medical Sciences, Department of Hematology, New Delhi, India (7 patients);
  • S. Apte and S. Kannan from Sahyadri Speciality Hospital, Pune, India (6 patients);
  • D.M. Nayak and A. Kurien from Melaka Manipal Medical College (Manipal campus), Manipal University, Karnataka, India (6 patients);
  • E. Santagostino and M.E. Mancuso from Angelo Bianchi Bonomi Hemophilia and Thrombosis Centre, IRCCS Ca’ Granda Maggiore Policlinico Hospital Foundation, Milan, Italy (6 patients);
  • A.C. Sandoval Gonzales and M.T. Pompa from Hospital de Especialidades UMAE, Istituto Mexicano del Seguro Social (IMSS), Monterrey, Mexico (5 patients);
  • J.N. Mahlangu and R. Schwyzer from Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, NHLS and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa  (4 patients);
  • S. Bonanad and S. Haya from Hospital Universitario La Fe, Unidad Coagulopatias Congenitas, Valencia, Spain  (3 patients);
  • M. Cerqueira and A.P. Marques from Centro de Pesquisa Clinica HEMORIO – Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti, Rio de Janeiro, Brazil (3 patients);
  • N.P. Ewing and C. DeGuzman from City of Hope National Medical Center, Duarte, California, USA (3 patients);
  • C. Male and K. Thom from Medizinische Universität Wien, Department of Paediatrics, Wien, Austria (3 patients);
  • T. Owaidah and M.M. Saleh from King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (3 patients);
  • V. Soto Arellano and D. Cortez Salazar from Centro de Hemofilicos del Hospital de Niños Dr. Roberto del Rio, Santiago, Chile (3 patients);
  • N.L. Kobrinsky from Sanford Roger Maris Cancer Center, Fargo, North Dakota, USA (2 patients);
  • S. Majumdar from University of Mississipi Medical Center, Division of Pediatric Hematology/Oncology, Jackson, Mississippi, USA (2 patients);
  • R. Perez Garrido and R. Nuñez Vazquez from Hospital Universitario Virgen del Rocio, Unidad de Hemofilia, Sevilla, Spain (2 patients);
  • A. Sachdeva and N. Radhakrishnan from Pediatric Hematology Oncology and Bone Marrow Transplantation Institute For Child Health Sir Ganga Ram Hospital, New Delhi, India (2 patients);
  • M. Simpson from Rush Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, Illinois, USA (2 patients);
  • M. Thomas from Kerala lnstitute of Medical Science, Kerala, India (2 patients);
  • E. Zanon and M. Milan from Clinica Medica II, Azienda Ospedaliera di Padova, Centro Emofilia, Padova, Italy (2 patients);
  • B. Antmen and I. Sasmaz from Cukurova Universitesi, Tip Fakultesi Pediatrik Hematoloji B.D., Adana, Turkey (1 patient);
  • K. Kavakli from Ege Universitesi Tip Fakultesi Cocuk Sagligive Hastalikari Anabilim Dali, Pediatrik Hematoloji Bilim Dali, Izmir, Turkey (1 patient);
  • M.J. Manco-Johnson from Hemophilia & Thrombosis Center, University of Colorado Denver, Aurora, Colorado, USA (1 patient);
  • M. Martinez from Hospital de Ninos Sor Maria Ludovica La Plata, Servicio de Hematologia, Buenos Aires, Argentina (1 patient);
  • E. Marzouka from Hospital de Ninos Dr. Luis Calvo Mackenna, Centro Hemofilico, Santiago, Chile (1 patient);
  • M.G. Mazzucconi and C. Santoro from Ematologia, UO Diagnostica Speciale e Terapia delle Malattie dell’Emostasi e della Trombosi, Università Sapienza, Policlinico Umberto I, Rome, Italy (1 patients);
  • D. Neme and L. Elhelou from Fundación de la Hemofilia, Buenos Aires, Argentina (1 patient);
  • A. Palomo Bravo from Hospital Regional Universitario Carlos Haya, Malaga, Spain (1 patient);
  • R. Paredes Aguilera from Instituto National de Pediatria, Ciudad de México, Mexico (1 patient);
  • A. Prezotti from Centro de Hematologia e Hemoterapia do Espírito Santo – Hemoes, Vitoria, Brazil (1 patient);
  • K. Schmitt and R. Schwarz from Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria (1 patient);
  • B.M. Wicklund from Children’s Mercy Hospital, Kansas City, Missouri, USA (1 patient);
  • B. Zulfikar and B. Koç from Istanbul Universitesi Cerrahpasa Tip Fakultesi, Pediatrik  Hematoloji B.D., Istanbul, Turkey (1 patient).

The SIPPET study was sponsored by the Fondazione Angelo Bianchi Bonomi

The contract research organization of SIPPET study was Sintesi Research

© 2017

Log in with your credentials

Forgot your details?